Related Experiment Videos
The composition of the depressive syndrome in acute schizophrenia
M Nakaya1, T Komahashi, K Ohmori
1Department of Psychiatry, Dokkyo University School of Medicine, Tochigi, Japan.
Insights
Depression in schizophrenia differs between acute and chronic phases. Specific symptoms like depressed mood and suicide risk are key indicators in both phases, aiding accurate assessment.
Area of Science:
- Psychiatry
- Clinical Psychology
- Neuroscience
Background:
- Depression is a common comorbidity in schizophrenia, impacting patient outcomes.
- Understanding the specific depressive symptoms in schizophrenia is crucial for effective treatment.
- The Hamilton Rating Scale for Depression (HRSD) is widely used but its applicability in schizophrenia requires further investigation.
Purpose of the Study:
- To analyze the composition of depressive syndromes in patients with schizophrenia during acute and chronic illness phases.
- To identify key discriminant symptoms of depression in schizophrenia using the HRSD.
- To compare the symptom profiles of depression in acute versus chronic schizophrenia.
Main Methods:
- A cohort of 86 newly admitted schizophrenia patients was studied.
- Discriminant analysis was employed using HRSD symptoms as variables.
- Patients were assessed during both acute and chronic stable phases of their illness.
Main Results:
- During the acute phase, nine HRSD symptoms significantly discriminated depression: depressed mood, guilt, suicide, retardation, three insomnia types, and two somatic symptoms.
- In the chronic stable phase, only four symptoms were significant: depressed mood, suicide, general somatic symptoms, and weight loss.
- Initial/middle insomnia, genital symptoms, and loss of insight were not strong discriminators in either phase.
Conclusions:
- The symptom profile of depression in schizophrenia varies significantly between acute and chronic phases.
- Certain HRSD items, such as depressed mood and suicide ideation, are consistently important across phases.
- Findings suggest a targeted use of specific HRSD items for depression assessment in schizophrenia.
Abstract:
The composition of the depressive syndrome was examined at both the acute and chronic phases of schizophrenic illness in 86 newly admitted patients. A subgroup with pronounced depression was defined, and a discriminant analysis was performed using symptoms from the Hamilton Rating Scale for Depression (HRSD) as discriminant variables. At the acute phase, the following nine symptoms from the HRSD were significant: depressed mood, guilt, suicide, retardation, three types of insomnia, and two somatic symptoms. At the chronic stable phase, only four symptoms were significant: depressed mood, suicide, general somatic symptoms, and loss of weight. Initial insomnia, middle insomnia, genital symptoms, and loss of insight were poorly correlated. The positive and negative symptoms and extrapyramidal side-effects were not discriminators at either phase. These findings suggest that only certain items from the HRSD may be crucial when assessing depression in schizophrenia.